Literature DB >> 16642401

The current understanding of the molecular determinants of inflammatory breast cancer metastasis.

Galina S Radunsky1, Kenneth L van Golen.   

Abstract

Inflammatory breast cancer is a highly aggressive and metastatic form of locally advanced breast cancer that carries a significantly worse prognosis than non-inflammatory breast cancers. Unfortunately, the molecular basis of this deadly form of breast cancer has been understudied. Over the past 10 years new studies have begun to reveal a unique molecular profile of IBC shedding light on its unique ability to rapidly invade and metastasize via the dermal lymphatic system of the skin overlying the breast. The goal of this review is to introduce IBC to the reader and provide a brief overview of what is known about the metastatic mechanisms of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642401     DOI: 10.1007/s10585-006-9000-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  54 in total

1.  Persistent E-cadherin expression in inflammatory breast cancer.

Authors:  C G Kleer; K L van Golen; T Braun; S D Merajver
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

2.  Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer.

Authors:  Guenther Gruber; Michele Ciriolo; Hans Joerg Altermatt; Stefan Aebi; Gilles Berclaz; Richard H Greiner
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

3.  A novel human xenograft model of inflammatory breast cancer.

Authors:  M L Alpaugh; J S Tomlinson; Z M Shao; S H Barsky
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

Review 4.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

5.  Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Authors:  François Bertucci; Pascal Finetti; Jacques Rougemont; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Carole Tarpin; Catherine Nguyen; Luc Xerri; Rémi Houlgatte; Jocelyne Jacquemier; Patrice Viens; Daniel Birnbaum
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  Epithelial-mesenchymal transition: NF-kappaB takes center stage.

Authors:  Margit A Huber; Hartmut Beug; Thomas Wirth
Journal:  Cell Cycle       Date:  2004-12-04       Impact factor: 4.534

7.  Strong association between c-myb and oestrogen-receptor expression in human breast cancer.

Authors:  M Guérin; Z M Sheng; N Andrieu; G Riou
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

8.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.

Authors:  S W Lee; C L Reimer; P Oh; D B Campbell; J E Schnitzer
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

Review 9.  The use of steroïd hormone receptors in the treatment of human breast cancer: a review.

Authors:  C K Osborne; W L McGuire
Journal:  Bull Cancer       Date:  1979       Impact factor: 1.276

Review 10.  Update on inflammatory breast cancer.

Authors:  Florence Lerebours; Ivan Bieche; Rosette Lidereau
Journal:  Breast Cancer Res       Date:  2005-01-20       Impact factor: 6.466

View more
  5 in total

Review 1.  Collective cell migration in morphogenesis, regeneration and cancer.

Authors:  Peter Friedl; Darren Gilmour
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07       Impact factor: 94.444

2.  Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?

Authors:  J-H Chen; R S Mehta; O Nalcioglu; M-Y Su
Journal:  Ann Surg Oncol       Date:  2008-09-19       Impact factor: 5.344

3.  Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.

Authors:  Rebecca L Hillyer; Padma Sirinvasin; Madhura Joglekar; Robert A Sikes; Kenneth L van Golen; Anja Nohe
Journal:  Clin Exp Metastasis       Date:  2012-05-20       Impact factor: 5.150

4.  Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).

Authors:  Madhura Joglekar-Javadekar; Steven Van Laere; Michael Bourne; Manal Moalwi; Pascal Finetti; Peter B Vermeulen; Daniel Birnbaum; Luc Y Dirix; Naoto Ueno; Monique Carter; Justin Rains; Abhijit Ramachandran; Francois Bertucci; Kenneth L van Golen
Journal:  Neoplasia       Date:  2017-06-10       Impact factor: 5.715

5.  RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.

Authors:  Alaa Zare; Alexandra Petrova; Mehdi Agoumi; Heather Amstrong; Gilbert Bigras; Katia Tonkin; Eytan Wine; Shairaz Baksh
Journal:  Cancers (Basel)       Date:  2018-06-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.